Mechanisms of Acceptance in Mouse Renal Allografts

小鼠肾同种异体移植物的接受机制

基本信息

  • 批准号:
    8260821
  • 负责人:
  • 金额:
    $ 43.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-15 至 2014-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This proposal addresses the need for definitive evidence on the role of Foxp3+/T regulatory cells in the acceptance of physiologically relevant full MHC incompatible organ grafts in various settings of operational tolerance. In the initial year of funding (ARRA), spontaneous acceptance of MHC-mismatched mouse renal allografts was shown to depend exquisitely on Foxp3 cells using diphtheria toxin (DT) to transiently deplete circulating and intragraft Foxp3 cells in B6.Foxp3DTR mice bearing life sustaining DBA/2 renal allografts. The accepted grafts had distinctive nodular perivascular infiltrates of Foxp3 cells and dendritic cells (DC). Deletion of foxp3 cells caused dissolution of the nodular aggregates and widespread infiltration of the cortex, tubules and blood vessels by T cells, typical of acute rejection, and manifested by a rise in BUN over 7 days. Similar nodular aggregates of Foxp3 cells occur in grafts of patients who have accepted MHC mismatched kidneys on mixed chimerism tolerance induction protocols. Specific aim 1 will extend these observations to other forms of induced tolerance, mixed chimerism and neonatal tolerance, some of which are expected to be Foxp3 dependent; those with deletional mechanisms are expected to be Foxp3 independent. We will seek distinctive pathologic features in the graft, indicating Treg activity, such as the co-expression of latency associated protein (LAP) and Foxp3 or DC expression of indoleamine 2,3-dioxygenase (IDO), that might be used to distinguish foxp3 dependent from foxp3 independent forms of graft acceptance. The donor reactivity and regulatory potential of the cells in grafts and in lymphoid organs will be tested by ELISPOT and compared between the different forms of acceptance and acute rejection. The dependence of systemic tolerance on the intragraft infiltrates will be tested by graft nephrectomy in recipients with accepted kidney and skin grafts that have a remaining native kidney. Specific aim 2 will seek to identify the molecular and cellular basis for the dramatic strain differences in susceptibility to spontaneous graft acceptance, comparing BALB/c (rejected) and DBA/2 (accepted) kidneys (both H-2d) in B6 recipients. We will test for strain differences in DC function, cytokine/chemokine/complement mediators, minor histocompatibility antigens and ability to generate Foxp3 cells. Follow-up experiments seek to alter identified factors to promote acceptance of BALB/c kidneys. Specific aim 3 visualize interaction of Foxp3+ cells with other T cells, recipient and donor dendritic cells and tubular cells in accepting and rejecting renal grafts using a custom real time confocal, multiphoton endomicroscope. This system permits observations of the same graft over time, live video recording, delineation of 3-4 different cell types and computer assisted measurement of cell motility and interactions. These studies are designed to reveal the significance and in vivo function of Foxp3+ Treg in murine renal allograft acceptance and provide insights potentially applicable in clinical renal transplantation. PUBLIC HEALTH RELEVANCE: The mouse kidney transplantation system offers an optimal combination of fidelity to human pathological processes, a rich spectrum of outcomes without drugs, and the ability to manipulate and observe the components of the immune response for mechanistic studies. These studies will provide insights into Treg physiology in renal allografts that will clarify their therapeutic relevance and reveal features that distinguish pathologic from beneficial intragraft infiltrates, of considerable importance in clinical transplantation and tolerance induction studies.
描述(由申请人提供):这项提案针对Foxp3+/T调节细胞在各种手术耐受环境下接受生理上相关的完全MHC不相容器官移植中所扮演的角色提出了明确的证据。在资助的最初一年(ARRA),MHC不匹配的小鼠肾移植的自发接受被证明非常依赖于使用白喉毒素(DT)的Foxp3细胞来瞬时耗尽B6Foxp3细胞和移植物内的Foxp3细胞。Foxp3DTR小鼠携带维持DBA/2肾移植的生命。移植血管周围有明显的结节状Foxp3细胞和树突状细胞(DC)浸润。Foxp3细胞的缺失导致结节聚集溶解,T细胞广泛侵入皮质、小管和血管,这是急性排斥反应的典型表现,表现为7天后BUN升高。在接受了混合嵌合耐受诱导方案的MHC不匹配肾脏的患者的移植肾中,也出现了类似的Foxp3细胞结节聚集体。具体目标1将把这些观察结果扩展到其他形式的诱导耐受、混合嵌合体和新生儿耐受,其中一些预计是Foxp3依赖的;那些具有缺失机制的应该是Foxp3不依赖的。我们将在移植物中寻找独特的病理特征,表明Treg活性,例如潜伏期相关蛋白(LAP)和Foxp3的共同表达或吲哚胺2,3-双加氧酶(IDO)的DC表达,这些可能被用来区分Foxp3依赖和Foxp3非依赖的移植物接受形式。ELISPOT将测试移植物和淋巴器官中细胞的供体反应性和调节潜力,并比较不同形式的接受和急性排斥反应。对于接受肾移植的受者,移植肾和皮肤移植物中剩余的天然肾脏,将通过移植物肾切除来测试全身耐受性对移植物内浸润物的依赖性。具体目标2将通过比较B6受者的BALB/c(排斥)和DBA/2(接受)肾脏(均为H-2d),试图确定B6受体BALB/c(排斥)和DBA/2(接受)肾脏在自发移植接受易感性方面存在显著差异的分子和细胞基础。我们将测试DC功能、细胞因子/趋化因子/补体介体、次要组织相容性抗原和产生Foxp3细胞的能力的菌株差异。后续实验试图改变已确定的因素,以促进BALB/c肾脏的接受。具体目的3使用定制的实时共聚焦多光子内窥镜观察Foxp3+细胞与其他T细胞、受者和供者树突状细胞以及肾小管细胞在接受和排斥肾移植过程中的相互作用。该系统允许随着时间的推移观察相同的移植物,实时视频记录,描绘3-4种不同的细胞类型,以及计算机辅助测量细胞的运动性和相互作用。这些研究旨在揭示Foxp3+Treg在小鼠肾移植接受中的意义和体内功能,并为临床肾移植提供潜在的可应用的见解。 与公共卫生相关:小鼠肾脏移植系统提供了与人类病理过程的保真度、丰富的不用药结果谱以及为机制研究操纵和观察免疫反应组件的能力的最佳组合。这些研究将提供对肾移植Treg生理学的见解,阐明它们的治疗相关性,并揭示区分病理和有益的移植物内浸润物的特征,这在临床移植和耐受诱导研究中具有相当重要的意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert B Colvin其他文献

Robert B Colvin的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert B Colvin', 18)}}的其他基金

Immunopathologic Studies
免疫病理学研究
  • 批准号:
    8432088
  • 财政年份:
    2012
  • 资助金额:
    $ 43.81万
  • 项目类别:
Immunopathologic Studies
免疫病理学研究
  • 批准号:
    8725788
  • 财政年份:
    2012
  • 资助金额:
    $ 43.81万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    8071240
  • 财政年份:
    2010
  • 资助金额:
    $ 43.81万
  • 项目类别:
Pathology
病理
  • 批准号:
    8134128
  • 财政年份:
    2010
  • 资助金额:
    $ 43.81万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    8462892
  • 财政年份:
    2010
  • 资助金额:
    $ 43.81万
  • 项目类别:
Mechanisms of Acceptance in Mouse Renal Allografts
小鼠肾同种异体移植物的接受机制
  • 批准号:
    7985705
  • 财政年份:
    2010
  • 资助金额:
    $ 43.81万
  • 项目类别:
Immunopathology
免疫病理学
  • 批准号:
    7680751
  • 财政年份:
    2009
  • 资助金额:
    $ 43.81万
  • 项目类别:
Mechanisms of acceptance of mouse renal allografts
小鼠同种异体肾移植物的接受机制
  • 批准号:
    7848042
  • 财政年份:
    2009
  • 资助金额:
    $ 43.81万
  • 项目类别:
Core--Pathology
核心--病理学
  • 批准号:
    7009886
  • 财政年份:
    2005
  • 资助金额:
    $ 43.81万
  • 项目类别:
CORE--IMMUNOPATHOLOGY
核心--免疫病理学
  • 批准号:
    6580448
  • 财政年份:
    2002
  • 资助金额:
    $ 43.81万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 43.81万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了